1. Home
  2. BRT vs PROF Comparison

BRT vs PROF Comparison

Compare BRT & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRT Apartments Corp. (MD)

BRT

BRT Apartments Corp. (MD)

HOLD

Current Price

$14.62

Market Cap

271.2M

Sector

Real Estate

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.66

Market Cap

263.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRT
PROF
Founded
1972
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
271.2M
263.8M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
BRT
PROF
Price
$14.62
$6.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$19.75
$12.00
AVG Volume (30 Days)
37.2K
137.4K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
7.03%
N/A
EPS Growth
N/A
25.89
EPS
N/A
N/A
Revenue
$97,028,000.00
$16,098,000.00
Revenue This Year
$3.82
$92.40
Revenue Next Year
$5.35
$64.10
P/E Ratio
N/A
N/A
Revenue Growth
1.46
50.73
52 Week Low
$13.18
$3.92
52 Week High
$16.69
$8.95

Technical Indicators

Market Signals
Indicator
BRT
PROF
Relative Strength Index (RSI) 50.34 43.59
Support Level $14.20 $6.24
Resistance Level $14.94 $7.03
Average True Range (ATR) 0.38 0.49
MACD 0.02 -0.09
Stochastic Oscillator 61.18 13.57

Price Performance

Historical Comparison
BRT
PROF

About BRT BRT Apartments Corp. (MD)

BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: